E2B(R3)

Enhancing Patient Safety: IDMP & ICH E2b(R3) Synergy

Since 2010, European Union (EU) Pharmacovigilance legislation is subject to regular and further enhancements because of EudraVigilance (EV), particularly the collection, management, and analysis of suspected adverse reaction reports. This…

Read Full Article